Sensitivity analyses to account for losses to follow-up in the antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

被引：0
|
作者：
Davis, BR [1 ]
Ford, C [1 ]
Pressel, S [1 ]
Dunn, K [1 ]
Piller, L [1 ]
机构：
[1] Univ Texas, Sch Publ Hlth, Houston, TX USA
来源：
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
68
引用
收藏
页码：76S / 76S
页数：1
相关论文
共 50 条
  • [21] Mortality and morbidity during and after the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Probstfield, J. L.
    Cushman, W. C.
    Davis, B. R.
    Pressel, S.
    Cutler, J. A.
    Einhorn, P.
    Ford, C.
    Oparil, S.
    Whelton, P.
    Wright, J. T.
    EUROPEAN HEART JOURNAL, 2010, 31 : 321 - 321
  • [22] Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Ernst, Michael E.
    Davis, Barry R.
    Soliman, Elsayed Z.
    Prineas, Ronald J.
    Okin, Peter M.
    Ghosh, Alokananda
    Cushman, William C.
    Einhorn, Paula T.
    Oparil, Suzanne
    Grimm, Richard H., Jr.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2016, 10 (12) : 930 - 938
  • [23] Stroke results in the antihypertensive and lipid lowering treatment to prevent heart attack trial
    Oparil, S
    Davis, B
    Nwachuku, C
    Pressel, S
    CIRCULATION, 2005, 112 (17) : U475 - U475
  • [24] Perspectives from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial - Lipid Lowering Trial and the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm
    Brown, WV
    Moussa, M
    CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (06) : 593 - 597
  • [25] Blood Pressure Control by Drug Group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Cushman, William C.
    Ford, Charles E.
    Einhorn, Paula T.
    Wright, Jackson T., Jr.
    Preston, Richard A.
    Davis, Barry R.
    Basile, Jan N.
    Whelton, Paul K.
    Weiss, Robert J.
    Bastien, Arnaud
    Courtney, Donald L.
    Hamilton, Bruce P.
    Kirchner, Kent
    Louis, Gail T.
    Retta, Tamrat M.
    Vidt, Donald G.
    JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (10): : 751 - 760
  • [26] Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Results by Sex
    Oparil, Suzanne
    Davis, Barry R.
    Cushman, William C.
    Ford, Charles E.
    Furberg, Curt D.
    Habib, Gabriel B.
    Haywood, L. Julian
    Margolis, Karen
    Probstfield, Jeffrey L.
    Whelton, Paul K.
    Wright, Jackson T., Jr.
    HYPERTENSION, 2013, 61 (05) : 977 - +
  • [27] Clinical outcomes in participants with cardiovascular dysmetabolic syndrome in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Davis, BR
    Black, HR
    CIRCULATION, 2004, 110 (17) : 796 - 796
  • [28] The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Juraschek, Stephen P.
    Simpson, Lara M.
    Davis, Barry R.
    Shmerling, Robert H.
    Beach, Jennifer L.
    Ishak, Anthony
    Mukamal, Kenneth J.
    JOURNAL OF HYPERTENSION, 2020, 38 (05) : 954 - 960
  • [29] Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Ebner, Christian
    JOURNAL FUR HYPERTONIE, 2009, 13 (03): : 36 - 38
  • [30] Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Davis, Barry R.
    Kostis, John B.
    Simpson, Lara M.
    Black, Henry R.
    Cushman, William C.
    Einhorn, Paula T.
    Farber, Michael A.
    Ford, Charles E.
    Levy, Daniel
    Massie, Barry M.
    Nawaz, Shah
    CIRCULATION, 2008, 118 (22) : 2259 - 2267
12345